Jason P Rhodes - Net Worth and Insider Trading
Jason P Rhodes Net Worth
The estimated net worth of Jason P Rhodes is at least $293 Million dollars as of 2024-11-13. Jason P Rhodes is the Director of Dyne Therapeutics Inc and owns about 8,050,704 shares of Dyne Therapeutics Inc (DYN) stock worth over $237 Million. Jason P Rhodes is the Director of Replimune Group Inc and owns about 3,228,912 shares of Replimune Group Inc (REPL) stock worth over $39 Million. Jason P Rhodes is also the Director of Generation Bio Co and owns about 8,279,484 shares of Generation Bio Co (GBIO) stock worth over $17 Million. Details can be seen in Jason P Rhodes's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Jason P Rhodes has not made any transactions after 2024-02-28 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.
Transaction Summary of Jason P Rhodes
Jason P Rhodes Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Jason P Rhodes owns 5 companies in total, including Dyne Therapeutics Inc (DYN) , Generation Bio Co (GBIO) , and Replimune Group Inc (REPL) among others .
Click here to see the complete history of Jason P Rhodes’s form 4 insider trades.
Insider Ownership Summary of Jason P Rhodes
Ticker | Comapny | Transaction Date | Type of Owner |
---|---|---|---|
DYN | Dyne Therapeutics Inc | 2024-02-28 | director & 10 percent owner |
GBIO | Generation Bio Co | 2021-09-29 | director |
REPL | Replimune Group Inc | 2021-01-26 | director |
2013-05-30 | 10 percent owner & EVP & CFO and Treasurer | ||
2021-10-04 | director & 10 percent owner |
Jason P Rhodes Latest Holdings Summary
Jason P Rhodes currently owns a total of 3 stocks. Among these stocks, Jason P Rhodes owns 8,050,704 shares of Dyne Therapeutics Inc (DYN) as of February 28, 2024, with a value of $237 Million and a weighting of 80.76%. Jason P Rhodes owns 3,228,912 shares of Replimune Group Inc (REPL) as of January 26, 2021, with a value of $39 Million and a weighting of 13.45%. Jason P Rhodes also owns 8,279,484 shares of Generation Bio Co (GBIO) as of September 29, 2021, with a value of $17 Million and a weighting of 5.79%.
Latest Holdings of Jason P Rhodes
Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
---|---|---|---|---|---|
DYN | Dyne Therapeutics Inc | 2024-02-28 | 8,050,704 | 29.38 | 236,529,684 |
REPL | Replimune Group Inc | 2021-01-26 | 3,228,912 | 12.20 | 39,392,726 |
GBIO | Generation Bio Co | 2021-09-29 | 8,279,484 | 2.05 | 16,972,942 |
Holding Weightings of Jason P Rhodes
Jason P Rhodes Form 4 Trading Tracker
According to the SEC Form 4 filings, Jason P Rhodes has made a total of 4 transactions in Dyne Therapeutics Inc (DYN) over the past 5 years, including 1 buys and 3 sells. The most-recent trade in Dyne Therapeutics Inc is the sale of 807,838 shares on February 28, 2024, which brought Jason P Rhodes around $20 Million.
According to the SEC Form 4 filings, Jason P Rhodes has made a total of 6 transactions in Replimune Group Inc (REPL) over the past 5 years, including 1 buys and 5 sells. The most-recent trade in Replimune Group Inc is the sale of 5,558 shares on January 26, 2021, which brought Jason P Rhodes around $256,446.
According to the SEC Form 4 filings, Jason P Rhodes has made a total of 6 transactions in Generation Bio Co (GBIO) over the past 5 years, including 0 buys and 6 sells. The most-recent trade in Generation Bio Co is the sale of 81,088 shares on September 29, 2021, which brought Jason P Rhodes around $2 Million.
Insider Trading History of Jason P Rhodes
- 1
Jason P Rhodes Trading Performance
GuruFocus tracks the stock performance after each of Jason P Rhodes's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Jason P Rhodes is 26.97%. GuruFocus also compares Jason P Rhodes's trading performance to market benchmark return within the same time period. The performance of stocks bought by Jason P Rhodes within 3 months outperforms 2 times out of 2 transactions in total compared to the return of S&P 500 within the same period.
You can select different timeframes to see how Jason P Rhodes's insider trading performs compared to the benchmark.
Performance of Jason P Rhodes
Jason P Rhodes Ownership Network
Ownership Network List of Jason P Rhodes
Ownership Network Relation of Jason P Rhodes
Jason P Rhodes Owned Company Details
What does Dyne Therapeutics Inc do?
Who are the key executives at Dyne Therapeutics Inc?
Jason P Rhodes is the director & 10 percent owner of Dyne Therapeutics Inc. Other key executives at Dyne Therapeutics Inc include director & 10 percent owner Dirk Kersten , See Remarks Richard William Scalzo , and Chief Operating Officer Susanna Gatti High .
Dyne Therapeutics Inc (DYN) Insider Trades Summary
Over the past 18 months, Jason P Rhodes made 3 insider transaction in Dyne Therapeutics Inc (DYN) with a net sale of 1,818,779. Other recent insider transactions involving Dyne Therapeutics Inc (DYN) include a net sale of 446,445 shares made by Dirk Kersten , a net sale of 327,516 shares made by Richard William Scalzo , and a net sale of 273,683 shares made by Susanna Gatti High .
In summary, during the past 3 months, insiders sold 1,741,587 shares of Dyne Therapeutics Inc (DYN) in total and bought 32,000 shares, with a net sale of 1,709,587 shares. During the past 18 months, 7,985,414 shares of Dyne Therapeutics Inc (DYN) were sold and 1,746,285 shares were bought by its insiders, resulting in a net sale of 6,239,129 shares.
Dyne Therapeutics Inc (DYN)'s detailed insider trading history can be found in Insider Trading Tracker table.
Dyne Therapeutics Inc Insider Transactions
Jason P Rhodes Mailing Address
Above is the net worth, insider trading, and ownership report for Jason P Rhodes. You might contact Jason P Rhodes via mailing address: C/o Epizyme, Inc., 400 Technology Square, 4th Floor, Cambridge Ma 02139.